Serotonin (5-hydroxytryptamine) 5-HT2A receptor: Association with inherent and cocaine-evoked behavioral disinhibition in rats

Behavioural Pharmacology

Volumn 22, Issue 3, 2011, Pages 248-261

  Anastasio, Noelle C ^a,b   Stoffel, Erin C ^a,b   Fox, Robert G ^a,b   Bubar, Marcy J ^a,b   Rice, Kenner C ^d   Moeller, Frederick G ^a,c   Cunningham, Kathryn A ^a,b,e  

^a Center for Addiction Research   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

5 HT2A receptor; behavioral disinhibition; cocaine; differential reinforcement of low rate task; impulsivity; one choice serial reaction time task; rat

Indexed keywords

COCAINE; SEROTONIN 2A ANTAGONIST; VOLINANSERIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; IMPULSE CONTROL DISORDER; IMPULSIVENESS; MALE; NONHUMAN; RAT; REACTION TIME; REINFORCEMENT;

ANIMALS; COCAINE; FLUOROBENZENES; IMPULSIVE BEHAVIOR; MALE; PIPERIDINES; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME; RECEPTOR, SEROTONIN, 5-HT2A; REINFORCEMENT (PSYCHOLOGY);

EID: 79955473049     PISSN: 09558810     EISSN: 14735849     Source Type: Journal    
DOI: 10.1097/FBP.0b013e328345f90d     Document Type: Article

References (89)

1. Ardayfio PA, Benvenga MJ, Chaney SF, Love PL, Catlow J, Swanson SP, Marek GJ (2008). The 5-hydroxytryptamine2A receptor antagonist R-( + )-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl-4-piperidinem ethanol (M100907) attenuates impulsivity after both drug-induced disruption (dizocilpine) and enhancement (antidepressant drugs) of differential- reinforcement-of-low-rate 72-s behavior in the rat. J Pharmacol Exp Ther 327:891-897.
2. Auclair A, Drouin C, Cotecchia S, Glowinski J, Tassin JP (2004). 5-HT2A and alpha1b-adrenergic receptors entirely mediate dopamine release, locomotor response and behavioural sensitization to opiates and psychostimulants. Eur J Neurosci 20:3073-3084. (Pubitemid 40007302)
3. Beck LH, Bransome ED Jr, Mirsky AF, Rosvold HE, Sarason I (1956). A continuous performance test of brain damage. J Consult Psychol 20:343-350.
4. Belin D, Mar AC, Dalley JW, Robbins TW, Everitt BJ (2008). High impulsivity predicts the switch to compulsive cocaine-taking. Science 320:1352-1355. (Pubitemid 351929473)
5. Bradberry CW, Roth RH (1989). Cocaine increases extracellular dopamine in rat nucleus accumbens and ventral tegmental area as shown by in vivo microdiaysis. Neurosci Lett 103:97-102. (Pubitemid 19207489)
6. Broderick PA, Olabisi OA, Rahni DN, Zhou Y (2004). Cocaine acts on accumbens monoamines and locomotor behavior via a 5-HT2A/2C receptor mechanism as shown by ketanserin: 24-h follow-up studies. Prog Neuro-psychopharmacol Biol Psychiatry 28:547-557. (Pubitemid 38490768)
7. 2R pharma-cotherapy in psychostimulant abuse. Prog Brain Res 172:319-346.
8. Bubar MJ, McMahon LR, De Deurwaerdere P, Spampinato U, Cunningham KA (2003). Selective serotonin reuptake inhibitors enhance cocaine-induced locomotor activity and dopamine release in the nucleus accumbens. Neuropharmacology 44:342-353. (Pubitemid 36246489)
9. Burmeister JJ, Lungren EM, Kirschner KF, Neisewander JL (2004). Differential roles of 5-HT receptor subtypes in cue and cocaine reinstatement of cocaine-seeking behavior in rats. Neuropsychopharmacol 29:660-668. (Pubitemid 38402473)
10. Cardinal RN, Robbins TW, Everitt BJ (2000). The effects of D-amphetamine, chlordiazepoxide, alpha-flupenthixol and behavioural manipulations on choice of signalled and unsignalled delayed reinforcement in rats. Psychopharma-cology (Berl) 152:362-375.
11. Carli M, Baviera M, Invernizzi RW, Balducci C (2006). Dissociable contribution of 5-HT1A and 5-HT2A receptors in the medial prefrontal cortex to different aspects of executive control such as impulsivity and compulsive persevera-tion in rats. Neuropsychopharmacol 31:757-767.
12. Carter BL, Tiffany ST (1999). Meta-analysis of cue-reactivity in addiction research. Addiction 94:327-340. (Pubitemid 29137413)
13. Coffey SF, Gudleski GD, Saladin ME, Brady KT (2003). Impulsivity and rapid discounting of delayed hypothetical rewards in cocaine-dependent individuals. Exp Clin Psychopharmacol 11:18-25. (Pubitemid 36237339)
14. Cole BJ, Robbins TW (1989). Effects of 6-hydroxydopamine lesions of the nucleus accumbens septi on performance of a 5-choice serial reaction time task in rats: implications for theories of selective attention and arousal. Behav Brain Res 33:165-179. (Pubitemid 19141065)
15. Dalley JW, Theobald DE, Eagle DM, Passetti F, Robbins TW (2002). Deficits in impulse control associated with tonically-elevated serotonergic function in rat prefrontal cortex. Neuropsychopharmacol 26:716-728. (Pubitemid 34455024)
16. Dalley JW, Fryer TD, Brichard L, Robinson ES, Theobald DE, Laane K, et al. (2007). Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science 315:1267-1270. (Pubitemid 46364262)
17. De Wit H, Richards JB (2004). Dual determinants of drug use in humans: reward and impulsivity. Nebr Symp Motiv 50:19-55.
18. 2C receptor agonist, RO 60-0175: a pharmacological analysis. Neuropharmacology 38:415-423. (Pubitemid 29097724)
19. Diergaarde L, Pattij T, Poortvliet I, Hogenboom F, De VW, Schoffelmeer AN, De Vries TJ (2008). Impulsive choice and impulsive action predict vulnerability to distinct stages of nicotine seeking in rats. Biol Psychiatry 63:301-308.
20. Evenden JL (1999). Impulsivity: a discussion of clinical and experimental findings. J Psychopharmacol 13:180-192.
21. Filip M (2005). Role of serotonin (5-HT)2 receptors in cocaine self-administration and seeking behavior in rats. Pharmacol Rep 57:35-46. (Pubitemid 40601539)
22. Filip M, Bubar MJ, Cunningham KA (2006). Contribution of serotonin (5-HT) 5-HT2 receptor subtypes to the discriminative stimulus effects of cocaine in rats. Psychopharmacology 183:482-489. (Pubitemid 41721150)
23. Fletcher PJ (1995). Effects of combined or separate 5,7- dihydroxytryptamine lesions of the dorsal and median raphe nuclei on responding maintained by a DRL 20 s schedule of food reinforcement. Brain Res 675:45-54.
24. Fletcher PJ, Grottick AJ, Higgins GA (2002). Differential effects of the 5-HT2A receptor antagonist M100,907 and the 5-HT2C receptor antagonist SB242,084 on cocaine-induced locomotor activity, cocaine self-administration and cocaine-induced reinstatement of responding. Neuropsychophar-macol 27:576-586.
25. Fletcher PJ, Tampakeras M, Sinyard J, Higgins GA (2007). Opposing effects of 5-HT(2A) and 5-HT(2C) receptor antagonists in the rat and mouse on premature responding in the five-choice serial reaction time test. Psycho-pharmacology (Berl) 195:223-234. (Pubitemid 350045843)
26. Fletcher PJ, Chambers JW, Rizos Z, Chintoh AF (2009). Effects of 5-HT depletion in the frontal cortex or nucleus accumbens on response inhibition measured in the 5-choice serial reaction time test and on a DRL schedule. Behav Brain Res 201:88-98.
27. Gresch PJ, Barrett RJ, Sanders-Bush E, Smith RL (2007). 5-Hydroxytryptamine (serotonin)2A receptors in rat anterior cingulate cortex mediate the discriminative stimulus properties of d-lysergic acid diethylamide. J Pharmacol Exp Ther 320:662-669. (Pubitemid 46147946)
28. Harrison AA, Everitt BJ, Robbins TW (1997). Central 5-HT depletion enhances impulsive responding without affecting the accuracy of attentional performance: interactions with dopaminergic mechanisms. Psychopharmacology (Berl) 133:329-342. (Pubitemid 27462805)
29. Higgins GA, Enderlin M, Haman M, Fletcher PJ (2003). The 5-HT2A receptor antagonist M100,907 attenuates motor and 'impulsive-type' behaviours produced by NMDA receptor antagonism. Psychopharmacology (Berl) 170: 309-319. (Pubitemid 37491611)
30. Hitchcock JM, Lister S, Fischer TR, Wettstein JG (1997). Disruption of latent inhibition in the rat by the 5-HT2 agonist DOI: effects of MDL 100,907, clozapine, risperidone and haloperidol. Behav Brain Res 88:43-49. (Pubitemid 27459691)
31. Jentsch JD, Taylor JR (1999). Impulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli. Psychopharmacology (Berl) 146:373-390. (Pubitemid 29513278)
32. Jolly DC, Richards JB, Seiden LS (1999). Serotonergic mediation of DRL 72 s behavior: receptor subtype involvement in a behavioral screen for anti-depressant drugs. Biol Psychiatry 45:1151-1162. (Pubitemid 29236556)
33. Kalivas PW, Duffy P (1990). Effect of acute and daily cocaine treatment on extracellular dopamine in the nucleus accumbens. Synapse 5:48-58. (Pubitemid 20110621)
34. Kehne JH, Baron BM, Carr AA, Chaney SF, Elands J, Feldman DJ, et al. (1996). Preclinical characterization of the potential of the putative atypical antipsychotic MDL 100,907 as a potent 5-HT2A antagonist with a favorable CNS safety profile. J Pharmacol Exp Ther 277:968-981.
35. Keppel G (1973). Design and analysis: a researcher's handbook. Englewood Cliffs, NJ: Prentice-Hall Inc.
36. Koe BK (1976). Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain. J Pharmacol Exp Ther 199:649-661. (Pubitemid 8015278)
37. Koob GF (1992). Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol Sci 13:177-184.
38. Koskinen T, Sirvio J (2001). Studies on the involvement of the dopaminergic system in the 5-HT2 agonist (DOI)-induced premature responding in a five-choice serial reaction time task. Brain Res Bull 54:65-75. (Pubitemid 32156917)
39. Koskinen T, Ruotsalainen S, Puumala T, Lappalainen R, Koivisto E, Mannisto PT, Sirvio J (2000). Activation of 5-HT2A receptors impairs response control of rats in a five-choice serial reaction time task. Neuropharmacology 39: 471-481. (Pubitemid 30052936)
40. Koskinen T, Haapalinna A, Sirvio J (2003). Alpha-adrenoceptor-mediated modulation of 5-HT2 receptor agonist induced impulsive responding in a 5-choice serial reaction time task. Pharmacol Toxicol 92:214-225. (Pubitemid 36513217)
41. Li AA, Marek GJ, Vosmer G, Seiden LS (1989). Long-term central 5-HT depletions resulting from repeated administration of MDMA enhances the effects of single administration of MDMA on schedule-controlled behavior of rats. Pharmacol Biochem Behav 33:641-664.
42. Liao RM, Chang YH (2001). Different effects of 5-HT receptor agonists on operant response in rats under DRL 10-s and DRL 30-s schedules. Proc Natl Sci Counc Repub China B 25:223-232.
43. Loos M, Staal J, Schoffelmeer AN, Smit AB, Spijker S, Pattij T (2010). Inhibitory control and response latency differences between C57BL/6J and DBA/2J mice in a Go/No-Go and 5-choice serial reaction time task and strain-specific responsivity to amphetamine. Behav Brain Res 214:216-224.
44. Marek GJ, Li AA, Seiden LS (1989). Evidence for invovlement of 5-hydroxytryptamine receptors in antidepressant like drug effects on differential reinforcement of low rate 72 second behavior. J Pharmacol Exp Ther 250:60-71.
45. Marek GJ, Martin-Ruiz R, Abo A, Artigas F (2005). The selective 5-HT2A receptor antagonist M100907 enhances antidepressant-like behavioral effects of the SSRI fluoxetine. Neuropsychopharmacol 30:2205-2215. (Pubitemid 41643971)
46. McCreary AC, Filip M, Cunningham KA (2003). Discriminative stimulus properties of ( + / - )-fenfluramine: the role of 5-HT2 receptor subtypes. Behav Neurosci 117:212-221. (Pubitemid 36384240)
47. McMahon LR, Cunningham KA (2001). Antagonism of 5-hydroxytryptamine(2a) receptors attenuates the behavioral effects of cocaine in rats. J Pharmacol Exp Ther 297:357-363. (Pubitemid 32242596)
48. Millan MJ, Lejeune F, Gobert A (2000). Reciprocal autoreceptor and hetero-receptor control of serotonergic, dopaminergic and noradrenergic transmission in the frontal cortex: relevance to the actions of antidepressant agents. J Psychopharmacol 14:114-138. (Pubitemid 30389486)
49. Mirsky AF, Rosvold HE (1960). The use of psychoactive drugs as aneuropsy-chological tool in studies of attention in man. In: Uhr L, Miller JG, editors. Drugs and behavior. New York: Wiley. pp. 375-392.
50. Modesto-Lowe V, Kranzler HR (1999). Using cue reactivity to evaluate medications for treatment of cocaine dependence: a critical review. Addiction 94:1639-1651.
51. Moeller FG, Barratt ES, Dougherty DM, Schmitz JM, Swann AC (2001a). Psychiatric aspects of impulsivity. Am J Psychiatry 158:1783-1793. (Pubitemid 33054770)
52. Moeller FG, Dougherty DM, Barratt ES, Schmitz JM, Swann AC, Grabowski J (2001b). The impact of impulsivity on cocaine use and retention in treatment. J Subst Abuse Treat 21:193-198. (Pubitemid 34037109)
53. Moeller FG, Dougherty DM, Barratt ES, Oderinde V, Mathias CW, Harper RA, Swann AC (2002). Increased impulsivity in cocaine dependent subjects independent of antisocial personality disorder and aggression. Drug Alcohol Depend 68:105-111. (Pubitemid 34880044)
54. Moeller FG, Barratt ES, Fischer CJ, Dougherty DM, Reilly EL, Mathias CW, Swann AC (2004). P300 event-related potential amplitude and impulsivity in cocaine-dependent subjects. Neuropsychobiology 50:167-173. (Pubitemid 39077838)
55. National Research Council (1996). Guide for the care and use of laboratory animlas. Washington, DC: National Academy Press.
56. Nic Dhonnchadha BA, Fox RG, Stutz SJ, Rice KC, Cunningham KA (2009). Blockade of the serotonin 5-HT2A receptor suppresses cue-evoked reinstatement of cocaine-seeking behavior in a rat self-administration model. Behav Neurosci 123:382-396.
57. O'Brien CP, Childress AR, Ehrman R, Robbins SJ (1998). Conditioning factors in drug abuse: can they explain compulsion? J Psychopharmacol 12: 15-22. (Pubitemid 28142995)
58. O'Donnell JM, Marek GJ, Seiden LS (2005). Antidepressant effects assessed using behavior maintained under a differential-reinforcement-of-low-rate (DRL) operant schedule. Neurosci Biobehav Rev 29:785-798. (Pubitemid 40755464)
59. Paine TA, Olmstead MC (2004). Cocaine disrupts both behavioural inhibition and conditional discrimination in rats. Psychopharmacology (Berl) 175:443-450. (Pubitemid 39362042)
60. Paine TA, Dringenberg HC, Olmstead MC (2003). Effects of chronic cocaine on impulsivity: relation to cortical serotonin mechanisms. Behav Brain Res 147:135-147. (Pubitemid 37491422)
61. Passetti F, Dalley JW, Robbins TW (2003). Double dissociation of serotonergic and dopaminergic mechanisms on attentional performance using a rodent five-choice reaction time task. Psychopharmacology (Berl) 165:136-145. (Pubitemid 36056990)
62. Pattij T, Vanderschuren LJ (2008). The neuropharmacology of impulsive behaviour. Trends Pharmacol Sci 29:192-199.
63. Pattij T, Broersen LM, Van der LJ, Groenink L, Van der GJ, Maes RA, Olivier B (2003). Operant learning and differential-reinforcement-of-low-rate 36-s responding in 5-HT1A and 5-HT1B receptor knockout mice. Behav Brain Res 141:137-145. (Pubitemid 36542961)
64. Pattij T, Broersen LM, Peter S, Olivier B (2004). Impulsive-like behavior in differential-reinforcement-of-low-rate 36 s responding in mice depends on training history. Neurosci Lett 354:169-171. (Pubitemid 38032860)
65. Perry JL, Larson EB, German JP, Madden GJ, Carroll ME (2005). Impulsivity (delay discounting) as a predictor of acquisition of IV cocaine self-administration in female rats. Psychopharmacology (Berl) 178:193-201. (Pubitemid 40379214)
66. 2C receptors. Mol Brain Res 23:163-178.
67. Richards JB, Sabol KE, Seiden LS (1993). DRL interresponse-time distributions: quantification by peak deviation analysis. J Exp Anal Behav 60:361-385.
68. Robbins TW (2002). The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry. Psychopharmacology (Berl) 163:362-380.
69. Robinson ES, Dalley JW, Theobald DE, Glennon JC, Pezze MA, Murphy ER, Robbins TW (2008). Opposing roles for 5-HT2A and 5-HT2C receptors in the nucleus accumbens on inhibitory response control in the 5-choice serial reaction time task. Neuropsychopharmacol 33:2398-2406.
70. Sabol KE, Richards JB, Layton K, Seiden LS (1995). Amphetamine analogs have differential effects on DRL 36-s schedule performance. Psychopharmacology (Berl) 121:57-65.
71. Santana N, Bortolozzi A, Serrats J, Mengod G, Artigas F (2004). Expression of serotonin1A and serotonin2A receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex. Cereb Cortex 14:1100-1109. (Pubitemid 39258165)
72. Sokolowski JD, Seiden LS (1999). The behavioral effects of sertraline, fluoxetine, and paroxetine differ on the differential-reinforcement-of-low-rate 72-second operant schedule in the rat. Psychopharmacology (Berl) 147:153-161. (Pubitemid 30010562)
73. Stoffel EC, Cunningham KA (2008). The relationship between the locomotor response to a novel environment and behavioral disinhibition in rats. Drug Alcohol Depend 92:69-78. (Pubitemid 350213237)
74. Tarter RE, Kirisci L, Kirillova GP, Gavaler J, Giancola P, Vanyukov MM (2007). Social dominance mediates the association of testosterone and neurobeha-vioral disinhibition with risk for substance use disorder. Psychol Addict Behav 21:462-468.
75. Van den Broek MD, Bradshaw CM, Szabadi E (1987). Behaviour of 'impulsive' and 'non-impulsive' humans in a temporal differentiaiont schedule of reinforcement. Pers Individual Differences 8:233-239.
76. Van Gaalen MM, Brueggeman RJ, Bronius PFC, Schoffelmeer ANM, Vanderschuren LJMJ (2006). Behavioral disinhibition requires dopamine receptor activation. Psychopharmacology (Berl) 187:73-85. (Pubitemid 43876919)
77. Vickers SP, Easton N, Malcolm CS, Allen NH, Porter RH, Bickerdike MJ, Kennett GA (2001). Modulation of 5-HT(2A) receptor-mediated head-twitch behaviour in the rat by 5-HT(2C) receptor agonists. Pharmacol Biochem Behav 69: 643-652. (Pubitemid 32758752)
78. Wang Q, Simpao A, Sun L, Falk JL, Lau CE (2001). Contribution of the active metabolite, norcocaine, to cocaine's effects after intravenous and oral administration in rats: pharmacodynamics. Psychopharmacology (Berl) 153:341-352. (Pubitemid 32125819)
79. Wenger GR, Wright DW (1990). Behavioral effects of cocaine and its interaction with D-amphetamine and morphine in rats. Pharmacol Biochem Behav 35:595-600. (Pubitemid 20115746)
80. Wettstein JG, Host M, Hitchcock JM (1999). Selectivity of action of typical and atypical anti-psychotic drugs as antagonists of the behavioral effects of 1-[2,5-dimethoxy-4-iodophenyl]-2-aminopropane (DOI). Prog Neuropsycho-pharmacol Biol Psychiatry 23:533-544. (Pubitemid 29274222)
81. Winstanley CA, Chudasama Y, Dalley JW, Theobald DE, Glennon JC, Robbins TW (2003). Intra-prefrontal 8-OH-DPAT and M100907 improve visuospatial attention and decrease impulsivity on the five-choice serial reaction time task in rats. Psychopharmacology (Berl) 167:304-314. (Pubitemid 36712978)
82. Winstanley CA, Dalley JW, Theobald DE, Robbins TW (2004a). Fractionating impulsivity: contrasting effects of central 5-HT depletion on different measures of impulsive behavior. Neuropsychopharmacol 29: 1331-1343. (Pubitemid 38780656)
83. Winstanley CA, Theobald DE, Dalley JW, Glennon JC, Robbins TW (2004b). 5-HT2A and 5-HT2C receptor antagonists have opposing effects on a measure of impulsivity: interactions with global 5-HT depletion. Psychopharmacology (Berl) 176:376-385. (Pubitemid 40012745)
84. Winstanley CA, Theobald DE, Dalley JW, Robbins TW (2005). Interactions between serotonin and dopamine in the control of impulsive choice in rats: therapeutic implications for impulse control disorders. Neuropsychopharma-col 30:669-682. (Pubitemid 40397073)
85. Winstanley CA, Theobald DE, Dalley JW, Cardinal RN, Robbins TW (2006a). Double dissociation between serotonergic and dopaminergic modulation of medial prefrontal and orbitofrontal cortex during a test of impulsive choice. Cereb Cortex 16:106-114. (Pubitemid 41746734)
86. Winstanley CA, Eagle DM, Robbins TW (2006b). Behavioral models of impulsivity in relation to ADHD: translation between clinical and preclinical studies. Clin Psychol Rev 26:379-395.
87. Winstanley CA, Laplant Q, Theobald DE, Green TA, Bachtell RK, Perrotti LI, et al. (2007). DeltaFosB induction in orbitofrontal cortex mediates tolerance to cocaine-induced cognitive dysfunction. J Neurosci 27:10497-10507. (Pubitemid 47502009)
88. Wogar MA, Bradshaw CM, Szabadi E (1992). Impaired acquisition of temporal differentiation performance following lesions of the ascending 5-hydroxy-tryptaminergic pathways. Psychopharmacology (Berl) 107:373-378. (Pubitemid 24345291)
89. Woolverton WL, Kandel D, Schuster CR (1978). Effects of repeated administration of cocaine on schedule-controlled behavior of rats. Pharmacol Biochem Behav 9:327-337. (Pubitemid 9011697)